Novavax Inc. buy Sievi
Start price
17.12.21
/
50%
€183.96
Target price
17.12.22
€240.00
Performance (%)
-37.46%
End price
10.01.22
€115.04
Summary
This prediction ended on 10.01.22 with a price of €115.04. The BUY prediction by Sievi for Novavax Inc. performed very badly with a performance of -37.46%. Sievi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | 10.495% | 10.495% | -36.763% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% |
According to Sievi what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Some uniques
Cons
Comments by Sievi for this prediction
In the thread Novavax Inc. diskutieren
Stopped prediction by Sievi for Novavax Inc.
Novavax Inc.
Start price
Target price
Perf. (%)
€148.30
04.10.21
04.10.21
-
04.10.22
04.10.22
2.14%
15.11.21
15.11.21
Could be worthwhile Investment >10% per year
Some uniques
